01 2VALENS MOLECULES PRIVATE LIMITED
02 1Xenex Laboratories Inc
01 1PHENAZOPYRIDINE DC PVP
02 1PHENAZOPYRIDINE HCL
03 1Phenazopyridine Hydrochloride
01 1Canada
02 2India
NDC Package Code : 62705-0122
Start Marketing Date : 2017-01-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62705-0126
Start Marketing Date : 2017-01-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68981-046
Start Marketing Date : 2021-04-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Phenazopyridine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Phenazopyridine, including repackagers and relabelers. The FDA regulates Phenazopyridine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Phenazopyridine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Phenazopyridine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Phenazopyridine supplier is an individual or a company that provides Phenazopyridine active pharmaceutical ingredient (API) or Phenazopyridine finished formulations upon request. The Phenazopyridine suppliers may include Phenazopyridine API manufacturers, exporters, distributors and traders.
click here to find a list of Phenazopyridine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Phenazopyridine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Phenazopyridine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Phenazopyridine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Phenazopyridine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Phenazopyridine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Phenazopyridine suppliers with NDC on PharmaCompass.
We have 2 companies offering Phenazopyridine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?